<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Mankind Pharma Limited

NSE: MANKIND · Lot size: 225

OverviewOption ChainOI AnalysisFII / DIIMax Pain

Mankind Pharma Limited FII & DII Activity

FII Net (₹ Cr)
-1,059.93
Buy 12,756.88 · Sell 13,816.81
DII Net (₹ Cr)
+2,966.89
Buy 18,753.06 · Sell 15,786.17
FII F&O Net (contracts)
+0
Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-04-21-1,059.93+2,966.89
2026-04-20+683.2-4,721.48
2026-04-18+683.2-4,721.48
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

FIIs sold ₹1059.93 Cr in cash today, reflecting risk-off positioning amid broader market outflows. DIIs stepped in strongly, buying ₹2966.89 Cr, offsetting foreign outflows with domestic appetite. Cash market dynamics show a clear divergence, with local institutions absorbing FII selling pressure.

Trend vs 5-Day Average

Today’s FII outflow breaks below their +₹683.2 Cr 5-day average, signaling a sharp shift in foreign sentiment. Conversely, DII inflows contrast starkly with their own ₹-4721.48 Cr 5-day average, marking a decisive reversal in domestic buying.

F&O Positioning Signal

FII F&O cash stood at ₹0 Cr, indicating no directional hedging or speculative buildup. However, the Index Futures Long/Short ratio at 1.2 suggests FIIs maintain a relatively bullish macro stance despite sectoral caution.

Implication for Finance

Persistent DII support amid FII sell-offs could stabilize pharmaceutical stocks like MANKIND and bolster sector resilience in early trading.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21

Related Analysis

Same Sector

ABB
ABB India Limited
Neutral
ABCAPITAL
Aditya Birla Capital Limited
Neutral
ADANIENSOL
Adani Energy Solutions Limited
Neutral
ADANIENT
Adani Enterprises Limited
Neutral
ADANIGREEN
Adani Green Energy Limited
Neutral

Frequently Asked Questions

What is FII net buying/selling in Mankind Pharma Limited today?▾
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹1,059.93 Cr (net selling) as of 2026-04-21. This market-wide figure applies to all F&O stocks including Mankind Pharma Limited.
What is DII activity in Mankind Pharma Limited today?▾
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹2,966.89 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Mankind Pharma Limited today?▾
FII net F&O position (index + stock futures combined) is +0 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Mankind Pharma Limited?▾
Block deal data for Mankind Pharma Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Mankind Pharma Limited stock price?▾
FII and DII flows are market-wide data — all F&O stocks including Mankind Pharma Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Mankind Pharma Limited's individual OI buildup type, this provides a directional framework.